New combo therapy shows promise for kids with advanced hodgkin lymphoma
NCT ID NCT02979522
First seen Nov 10, 2025 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tested a new combination of a targeted drug (brentuximab vedotin) with standard chemotherapy in 59 children and teens with advanced, newly diagnosed Hodgkin lymphoma. The goal was to find the safest dose and see how well the treatment shrinks tumors. Early results suggest the combination may help more children achieve complete remission, but long-term follow-up is needed to confirm benefits and risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Citta della Salute e della Scienza di Torino
Torino, 10126, Italy
-
Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer
Florence, 50139, Italy
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
-
GRAACC - Grupo de Apoio ao Adolescente e a Crianca com Cancer
São Paulo, 04023-062, Brazil
-
Hospital Santa Marcelina
São Paulo, 08270-070, Brazil
-
Hospital Sao Rafael S/A
Salvador, Estado de Bahia, 41253-190, Brazil
-
ICr - Instituto da Crianca - HCFMUSP
São Paulo, 05403-000, Brazil
-
INCA - Instituto Nacional de Cancer
Rio de Janeiro, 20230-230, Brazil
-
Jardim das Americas
Paranã, 81520-060, Brazil
-
NHO Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
Ospedale Pediatrico Bambino Gesu,UOC Onco-ematologia
Roma, 165, Italy
-
St. Marianna University School of Medicine Hospital
Kawasaki-shi, Kanagawa, 216-8511, Japan
Conditions
Explore the condition pages connected to this study.